Obesity-associated improvements in metabolic profile through expansion of adipose tissue
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Excess caloric intake can lead to insulin resistance. The underlying reasons are complex but likely related to ectopic lipid deposition in nonadipose tissue. We hypothesized that the inability to appropriately expand subcutaneous adipose tissue may be an underlying reason for insulin resistance and beta cell failure. Mice lacking leptin while overexpressing adiponectin showed normalized glucose and insulin levels and dramatically improved glucose as well as positively affected serum triglyceride levels. Therefore, modestly increasing the levels of circulating full-length adiponectin completely rescued the diabetic phenotype in ob/ob mice. They displayed increased expression of PPARgamma target genes and a reduction in macrophage infiltration in adipose tissue and systemic inflammation. As a result, the transgenic mice were morbidly obese, with significantly higher levels of adipose tissue than their ob/ob littermates, leading to an interesting dichotomy of increased fat mass associated with improvement in insulin sensitivity. Based on these data, we propose that adiponectin acts as a peripheral "starvation" signal promoting the storage of triglycerides preferentially in adipose tissue. As a consequence, reduced triglyceride levels in the liver and muscle convey improved systemic insulin sensitivity. These mice therefore represent what we believe is a novel model of morbid obesity associated with an improved metabolic profile.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Adiponectin, for example, has been shown to induce angiogenesis in hypoxic fat pads and tumors (75,91)”
From Adipose tissue remodeling and obesity (2011) · cites this paper as [91]
Experimental — accuracy not yet measuredIn the citing paper
“These results are comparable to findings in which increasing the capacity of adipose tissue (66) or the liver (67) to incorporate fatty acids into TGs does not cause insulin resistance and can actually prevent HFD-induced insulin resistance (66).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [66]
In the citing paper
“we have previously demonstrated that overexpression of adiponectin in an ob/ob background improves vascularization and expansion of the subcutaneous fat pad in particular (91)”
From Adipose tissue remodeling and obesity (2011) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7463 · Cited by 3,541
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Kanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682
Cinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., Faloia, E., Wang, S., Fortier, M., Greenberg, A. S., & Obin, M. S. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500294-jlr200 · Cited by 2,529
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526
Self-citationDamiola, F., Le Minh, N., Preitner, N., Kornmann, B., Fleury-Olela, F., & Schibler, U. (2000) · Genes & Development · doi:10.1101/gad.183500 · Cited by 2,394
Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561
Self-citationCCR2 modulates inflammatory and metabolic effects of high-fat feeding
Weisberg, S. P., Hunter, D., Huber, R., Lemieux, J., Slaymaker, S., Vaddi, K., Charo, I., Leibel, R. L., & Jr., A. W. F. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24335 · Cited by 1,497
Cited by
Items 601–700 of 996
VAT fat is bad for the liver, SAT fat is not!
Fan, J., & Farrell, G. C. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05474.x · Cited by 39
Group X secretory phospholipase A 2 negatively regulates adipogenesis in murine models
Li, X., Shridas, P., Forrest, K. J., Bailey, W. M., & Webb, N. R. (2010) · The FASEB Journal · doi:10.1096/fj.10-154716 · Cited by 46
Major components of metabolic syndrome and adiponectin levels: a cross-sectional study
von Frankenberg, A. D., do Nascimento, F. V., Gatelli, L. E., Nedel, B. L., Garcia, S. P., de Oliveira, C. S., Saddi-Rosa, P., Reis, A. F., Canani, L. H. S., & Gerchman, F. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-26 · Cited by 41
“Adiponectin also promotes fatty acid oxidation in the liver and adipocytes, decreasing triglycerides levels [19-22] and increasing glucose uptake by skeletal muscles [23,24].”
BackgroundOrchestration of the Adipose Tissue Immune Landscape by Adipocytes
Bradley, D. P., Deng, T., Shantaram, D., & Hsueh, W. A. (2024) · Annual Review of Physiology · doi:10.1146/annurev-physiol-042222-024353 · Cited by 46
Enhanced Fatty Acid Flux Triggered by Adiponectin Overexpression
Shetty, S., Ramos-Román, M. A., Cho, Y.-R., Brown, J. D., Plutzky, J., Muise, E. S., Horton, J. D., Scherer, P. E., & Parks, E. J. (2011) · Endocrinology · doi:10.1210/en.2011-1339 · Cited by 39
Self-citationInactivation of SPARC enhances high-fat diet-induced obesity in mice
Nie, J., Bradshaw, A. D., Delany, A. M., & Sage, E. H. (2010) · Connective Tissue Research · doi:10.3109/03008207.2010.483747 · Cited by 40
CCN5/WISP2 and metabolic diseases
Grünberg, J. R., Elvin, J., Paul, A., Hedjazifar, S., Hammarstedt, A., & Smith, U. (2017) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-017-0437-z · Cited by 44
“This leads to an extreme obesity, but of a metabolically Bhealthy^ phenotype with many small and insulin- sensitive cells (Kim et al. 2007).”
Huang, L. O., Loos, R. J. F., & Kilpeläinen, T. O. (2018) · Physiological Genomics · doi:10.1152/physiolgenomics.00044.2017 · Cited by 45
Fan, R., You, M., Toney, A. M., Kim, J., Giraud, D., Xian, Y., Ye, F., Gu, L., Ramer‐Tait, A. E., & Chung, S. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900995 · Cited by 40
Self-citationGoedecke, J. H., Evans, J., Keswell, D., Stimson, R. H., Livingstone, D. E. W., Hayes, P. M., Adams, K., Dave, J. A., Victor, H., Levitt, N. S., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1576 · Cited by 45
“Reduced adipogenic capacity of SAT is typically associated with increased adipose cell size (6), apoptosis, inflammation, reduced vascularization and insulin signaling within adipose tissue (7), and peripheral insulin resistance (8).”
BackgroundBelalcazar, L. M., Lang, W., Haffner, S. M., Hoogeveen, R. C., Pi-Sunyer, F. X., Schwenke, D. C., Balasubramanyam, A., Tracy, R. P., Kriska, A. P., & Ballantyne, C. M. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m030213 · Cited by 37
Obesity, endocrine disruption and male infertility
Dutta, S., Biswas, A., & Sengupta, P. (2019) · Asian Pacific Journal of Reproduction · doi:10.4103/2305-0500.268133 · Cited by 47
“[50] Kim JY, Van De Wall E, Laplante M, Azzara A, Trujillo ME, Hofmann”
BackgroundAnti-inflammatory role of Gpnmb in adipose tissue of mice
Nickl, B., Qadri, F., & Bäder, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-99090-6 · Cited by 39
Adipocytokines: modern definition, classification and physiological role
Маркова, Т. Н., Mishchenko, N. K., & Petina, D. V. (2021) · Problems of Endocrinology · doi:10.14341/probl12805 · Cited by 51
Pan, L., Xu, Q., Liu, J., Gao, Y., Li, J., Peng, H., Chen, L., Wang, M., Mai, G., & Yang, S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.959860 · Cited by 40
“(26) found in animal experiments that adipose tissue could be a buffer against risk factors for metabolic disorders.”
BackgroundInsulin and insulin signaling play a critical role in fat induction of insulin resistance in mouse
Ning, J., Hong, T., Yang, X., Mei, S., Liu, Z., Liu, H.-Y., & Cao, W. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00164.2011 · Cited by 37
Kusmic, C., L’Abbate, A., Sambuceti, G., Drummond, G., Barsanti, C., Matteucci, M., Cao, J. J., Piccolomini, F., Cheng, J., & Abraham, N. G. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22486 · Cited by 39
“In particular, adiponectin has attracted considerable attention as it has insulinsensitizing properties that reduce serum triglyceride levels, enhance fatty acid oxidation and glucose uptake in the liver [Berg et al., 2001; Kim et al., 2007].”
BackgroundFrigolet, M. E., Torres, N., Uribe-Figueroa, L., Rangel‐Escareño, C., Jiménez‐Sánchez, G., & Tovar, A. R. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.12.006 · Cited by 40
“High expression of PPARγ, an essential transcription factor for preadipocyte differentiation, has been associated with a decrease in systemic inflammation accompanied by a decrease in adipocyte expression of proinflammatory cytokines [43].”
BackgroundChan, D. C., Pang, J., & Watts, G. F. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0472-7 · Cited by 40
Rhee, K., Lee, C.-G., Kim, S. W., Gim, D.-H., Kim, H., & Jung, B.-D. (2015) · International Journal of Medical Sciences · doi:10.7150/ijms.13339 · Cited by 42
“Obesity is the main cause of type 2 diabetes mellitus [34].”
BackgroundTamucci, K. A., Namwanje, M., Fan, L., & Qiang, L. (2018) · Protein & Cell · doi:10.1007/s13238-017-0434-2 · Cited by 36
“Adipoq knock-out mice show increased thermogenic response (Qiao et al. 2014), in line with the decreased energy expenditure in its transgenic mice on ob/ob background (Kim et al. 2007).”
BackgroundGarcía‐Carrizo, F., Priego, T., Szostaczuk, N., Palou, A., & Picó, C. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00445 · Cited by 39
“Moreover, adiponectin has been proposed to contribute to sex differences in insulin sensitivity (Medrikova et al., 2012), and some of its beneficial metabolic effects have been related to its involvement in WAT expandability (Kim et al., 2007; Asterholm and Scherer, 2010; Medrikova et al., 2012).”
BackgroundAdiponectin for the treatment of diabetic nephropathy
Lee, J. Y., Yang, J. W., Han, B. G., Choi, S. O., & Kim, J. S. (2019) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2019.109 · Cited by 39
“Furthermore, the preference of adiponectin for subcutaneous fat reduces the quantity of visceral fat and the fat mass of other organs, thereby improving fat tissue quality and insulin sensitivity [30].”
BackgroundSelf-citationObesity-Related Insulin Resistance: The Central Role of Adipose Tissue Dysfunction
Mocciaro, G., & Gastaldelli, A. (2022) · Handbook of experimental pharmacology · doi:10.1007/164_2021_573 · Cited by 48
Obestatin: A new metabolic player in the pancreas and white adipose tissue
Gesmundo, I., Gallo, D., Favaro, E., Ghigo, E., & Granata, R. (2013) · IUBMB Life · doi:10.1002/iub.1226 · Cited by 35
“These results suggested expansion of WAT and increased protection against diet-induced insulin resistance (74).”
Sutanto, M. M., Ferguson, K. K., Sakuma, H., Ye, H., Brady, M. J., & Cohen, R. N. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.107680 · Cited by 35
Peterson, S. J., Vanella, L., Gotlinger, K. H., Jiang, H., Singh, S. P., Sodhi, K., Maher, E., O'Hanlon, K. M., Shapiro, J. I., & Abraham, N. G. (2016) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2016.04.004 · Cited by 38
Ullah, H., Filippis, A. D., Khan, H. Z., Xiao, J., & Daglia, M. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111574 · Cited by 51
S1P/S1PR3 signalling axis protects against obesity-induced metabolic dysfunction
Chakrabarty, S., Bui, Q., Badeanlou, L., Hester, K. D., Chun, J. J. M., Ruf, W., Ciaraldi, T. P., & Samad, F. (2022) · Adipocyte · doi:10.1080/21623945.2021.2021700 · Cited by 41
“adiposity per-se contributes to metabolic abnormalities [42] [43,44].”
BackgroundDietary modification dampens liver inflammation and fibrosis in obesity-related fatty liver disease
Larter, C. Z., Yeh, M. M., Haigh, W. G., Rooyen, D. M. V., Brooling, J. T., Heydet, D., Nolan, C. J., Teoh, N., & Farrell, G. C. (2013) · Obesity · doi:10.1002/oby.20123 · Cited by 41
“, such adipose expansion reversed diabetes and partly restored serum adiponectin levels (26).”
BackgroundTurco, S. D., Navarra, T., Gastaldelli, A., & Basta, G. (2011) · Microvascular Research · doi:10.1016/j.mvr.2011.03.003 · Cited by 35
“Whether this effect is a direct effect of increased adiponectin levels or the result of the overall increase in weight is not known to date (Kim et al., 2007).”
BackgroundMoreno‐Navarrete, J. M., Petrov, P., Serrano, M., Ortega, F. J., García-Ruiz, E., Oliver, P., Ribot, J., Ricart, W., Palou, A., Bonet, M. L., et al. (2013) · Diabetes · doi:10.2337/db12-0977 · Cited by 40
“Several studies suggest that one of the key factors that link excess caloric intake and a positive energy balance with metabolic disturbance is the inability to appropriately expand the adipose tissue, which occurs in parallel to the decrease of its adipogenic capacity (1,2).”
BackgroundGrünberg, J. R., Hoffmann, J. M., Hedjazifar, S., Nerstedt, A., Jenndahl, L., Elvin, J., Castellot, J., Wei, L., Movérare-Skrtic, S., Ohlsson, C., et al. (2017) · Scientific Reports · doi:10.1038/srep43515 · Cited by 35
“This protective effect of a hyperplastic adipose tissue was clearly demonstrated in a mouse model overexpressing adiponectin in the adipose tissue 5 .”
BackgroundImproving Adiponectin Levels in Individuals With Diabetes and Obesity: Insights From Look AHEAD
Belalcazar, L. M., Lang, W., Haffner, S. M., Schwenke, D. C., Kriska, A. M., Balasubramanyam, A., Hoogeveen, R. C., Pi‐Sunyer, F. X., Tracy, R. P., & Ballantyne, C. M. (2015) · Diabetes Care · doi:10.2337/dc14-2775 · Cited by 38
The Role of Adiponectin in Maintaining Metabolic Homeostasis
Adıyaman, S. C., Özer, M., Saydam, B. Ö., & Akıncı, B. (2019) · Current Diabetes Reviews · doi:10.2174/1573399815666190702155733 · Cited by 41
Adipose tissue and ovarian aging: Potential mechanism and protective strategies
Wu, M., Huang, Y., Zhu, Q., Zhu, X., Xue, L., Xiong, J., Chen, Y., Wu, C., Guo, Y., Li, Y., et al. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101683 · Cited by 36
Hong, X., Zhang, X., You, L., Li, F., Lian, H., Wang, J., Mao, N., Ren, M., Yan, L., Wang, C., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2021-060377 · Cited by 42
Richard, A. J., Burris, T. P., Sánchez‐Infantes, D., Wang, Y., Ribnicky, D., & Stephens, J. M. (2014) · Nutrition · doi:10.1016/j.nut.2014.02.013 · Cited by 33
Kumar, N. P., Nair, D., Banurekha, V. V., Dolla, C., Kumaran, P., Sridhar, R., & Babu, S. (2016) · Cytokine · doi:10.1016/j.cyto.2015.12.026 · Cited by 39
“In animal models, mice over expressing adiponectin showed regulated glucose and partial improvement of insulin resistance and diabetes and a decrease in macrophage infiltration in adipose tissue and systemic inflammation [26].”
BackgroundA mouse model for a partially inactive obesity-associated human MC3R variant
Lee, B., Koo, J., Jun, J. Y., Gavrilova, O., Lee, Y., Seo, A. Y., Taylor-Douglas, D. C., Adler‐Wailes, D. C., Chen, F., Gardner, R., et al. (2016) · Nature Communications · doi:10.1038/ncomms10522 · Cited by 36
Extracellular Vesicles in Adipose Tissue Communication with the Healthy and Pathological Heart
Michel, L. Y. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097745 · Cited by 36
“Adipocyte-derived adiponectin is crucial for the maintenance of global glucose homeostasis and insulin sensitivity [26,27].”
BackgroundInterplay of pro- and anti-inflammatory cytokines to determine lipid accretion in adipocytes
Wang, Y., Wang, H., Hegde, V. K., Dubuisson, O. S., Gao, Z., Dhurandhar, N. V., & Ye, J. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.9 · Cited by 36
Adipose proteome analysis: focus on mediators of insulin resistance
Chen, X., & Hess, S. Y. (2008) · Expert Review of Proteomics · doi:10.1586/14789450.5.6.827 · Cited by 35
Pan, Z., Zhou, Z., Zhang, H., Zhao, H., Song, P., Wang, D., Yin, J., Zhao, W., Xie, Z., Wang, F., et al. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1459-7 · Cited by 36
Dankel, S. N., Grytten, E., Bjune, J.-I., Nielsen, H. J., Dietrich, A., Blüher, M., Sagen, J. V., & Mellgren, G. (2020) · Scientific Reports · doi:10.1038/s41598-020-77406-2 · Cited by 34
Asc-1 regulates white versus beige adipocyte fate in a subcutaneous stromal cell population
Suwandhi, L., Altun, I., Karlina, R., Miok, V., Wiedemann, T., Fischer, D. S., Walzthoeni, T., Lindner, C., Böttcher, A., Heinzmann, S. S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21826-9 · Cited by 36
Nonalcoholic fatty liver disease shows significant sex dimorphism
Chen, X., Wang, C., Huang, Y., & Zhang, L. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i5.1457 · Cited by 40
Ardiansyah, A., Shirakawa, H., Sugita, Y., Koseki, T., & Komai, M. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510000255 · Cited by 33
“It is well known that adiponectin plays a central role in antagonising the metabolic parameters involved in obesity, hepatic lipid deposition and inflammation that ultimately lead to systemic insulin resistance (37) .”
Regulation of adipogenesis by nucelar receptor PPARγ is modulated by the histone demethylase JMJD2C
Lizcano, F., Carolina, R., & Vargas, D. (2010) · Genetics and Molecular Biology · doi:10.1590/s1415-47572010005000105 · Cited by 46
“Secretions from adipocyte cells include a variety of proteins that affect other organs and can cause complications (Kim et al., 2007).”
BackgroundThe Therapeutic Potential of the Adiponectin Pathway
Gu, W., & Li, Y. (2011) · BioDrugs · doi:10.2165/11594790-000000000-00000 · Cited by 36
The immune cell transcription factor T-bet: A novel metabolic regulator
Stolarczyk, E., Lord, G. M., & Howard, J. K. (2014) · Adipocyte · doi:10.4161/adip.26220 · Cited by 32
“Increased adiposity has been reported without adverse metabolic effects in the context of transgenic overexpression of adiponectin in the obese, leptin-deficient ob/ob mouse.(25) It is possible that T-bet may interact with peroxisome proliferator-activated receptor gamma (PPAR-γ) signaling pathways.”
BackgroundYu, D., Yu, Z., Sun, Q., Sun, L., Li, H., Song, J., Mi, M., Wu, H., Lu, L., Liu, C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016818 · Cited by 36
“. Kim et al. found if leptin-deficient mice have over-expressed adiponectin would result in improvements of glucose and lipid metabolism and inflammatory profile”
BackgroundSelf-citationThe Inhibitory Role of α2,6-Sialylation in Adipogenesis
Kaburagi, T., Kizuka, Y., Kitazume, S., & Taniguchi, N. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.747667 · Cited by 37
“Obesity results from excess accumulation of adipose tissue with hypertrophy and hyperplasia of adipocytes (5–9), which leads to abnormal secretion of adipocytokines (6, 7) and triggers various diseases, including diabetes and cardiovascular diseases (2, 6, 7, 10).”
BackgroundThe Potential Role of Exosomes in Child and Adolescent Obesity
Maligianni, I., Yapijakis, C., Bacopoulou, F., & Chrousos, G. P. (2021) · Children · doi:10.3390/children8030196 · Cited by 32
Cytoplasmic receptor-interacting protein 140 (RIP140) interacts with perilipin to regulate lipolysis
Ho, P., Chuang, Y.-S., Hung, C.-H., & Wei, L. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.03.023 · Cited by 35
Richey, J. M., Woolcott, O. O., Stefanovski, D., Harrison, L. N., Zheng, D., Lottati, M., Hsu, I. R., Kim, S. P., Kabir, M., Catalano, K. J., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90972.2008 · Cited by 32
“It has been reported that overexpression of adiponectin in mice resulted in expansion of SAT and was associated with an improvement of the metabolic profile (22).”
BackgroundBonzón‐Kulichenko, E., Moltó, E., Pintado, C., Fernández, A., Arribas, C., Schwudke, D., Gallardo, N., Shevchenko, A., & Andrés, A. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly081 · Cited by 40
“Moreover, increasing the capacity of the white adipose tissue (WAT) to expand in ob/ob mice normalizes all the metabolic parameters despite the obese phenotype (20).”
BackgroundOsteoarthritis Is a Low-Grade Inflammatory Disease: Obesity’s Involvement and Herbal Treatment
Zeddou, M. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/2037484 · Cited by 39
“Importantly, free fatty acids, which are abundant in obese patients, are ligands of the membrane-bound TLR4 and can promote inflammation [57, 58].”
BackgroundHypothalamic POMC deficiency increases circulating adiponectin despite obesity
Yu, H. M., Chhabra, K. H., Thompson, Z., Jones, G. L., Kiran, S., Shangguan, G., & Low, M. J. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.01.021 · Cited by 35
“Overexpression of adiponectin in ob/ob mice actually leads to increased body weight and fat mass specifically in subcutaneous fat depots [44].”
BackgroundJayashankar, V., Selwan, E. M., Hancock, S. E., Verlande, A., Goodson, M. O., Eckenstein, K. H., Milinkeviciute, G., Hoover, B., Chen, B., Fleischman, A. G., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202013086 · Cited by 33
“Increasing adiponectin levels is an important therapeutic goal given that it improves insulin sensitivity, reduces inflammation, and improves metabolic function in obesity models (Xu et al, 2003; Kim et al, 2007; Gastaldelli et al, 2010; Phillips & Kung, 2010).”
BackgroundFate of adipocyte progenitors during adipogenesis in mice fed a high-fat diet
Bilal, M., Nawaz, A., Kado, T., Aslam, M. R., Igarashi, Y., Nishimura, A., Watanabe, Y., Kuwano, T., Liu, J., Miwa, H., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101328 · Cited by 38
Nunn, E. R., Shinde, A. B., & Zaganjor, E. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.821278 · Cited by 35
Singh, S. P., Niemczyk, M., Zimniak, L., & Zimniak, P. (2008) · Aging · doi:10.18632/aging.100005 · Cited by 40
“Recent data indicate that the primary trigger of metabolic syndrome in mammals is not total but ectopic fat, and that fat in adipose tissue may play a lesser role or could actually be protective by preventing the accretion of ectopic fat [65, 67-71].”
BackgroundHuang, Z., Minshall, R. D., & Mazzone, T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.004754 · Cited by 32
Na, H.-N., Kim, S., & Jh, N. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.89 · Cited by 35
Recombinant Adiponectin Does Not Lower Plasma Glucose in Animal Models of Type 2 Diabetes
Tullin, S., Sams, A. G., Brandt, J., Dahl, K., Gong, W., Jeppesen, C. B., Krogh, T. N., Olsen, G. S., Liu, Y., Pedersen, A. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044270 · Cited by 31
“Leptin deficient ob/ ob mice with transgenic over expression of adiponectin in adipose tissue have normal levels of plasma glucose, insulin, non-esterified fatty acids and triglycerides even though the animals are significantly more obese than their non-transgenic ob/ob littermates [12].”
BackgroundInsulin resistance, adipose depots and gut: Interactions and pathological implications
Gastaldelli, A., Natali, A., Vettor, R., & Corradini, S. G. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.01.013 · Cited by 46
“Rather, visceral fat releases adipokines which could be implicated in skeletalmuscle IR [63,71,90] although in vivo secretion rates of most adipokines from VAT are probably not greater than the secretion rates from subcutaneous adipose tissue [93] (Fig.”
BackgroundCaffeic Acid Phenethyl Ester Regulates PPAR’s Levels in Stem Cells-Derived Adipocytes
Vanella, L., Tibullo, D., Godos, J., Pluchinotta, F. R., Giacomo, C. D., Sorrenti, V., Acquaviva, R., Russo, A., Volti, G. L., & Barbagallo, I. A. (2016) · PPAR Research · doi:10.1155/2016/7359521 · Cited by 35
“In the context of TZD, this effect critically depends on their ability to induce PPARγ and adiponectin levels [56, 57].”
Harris, R. B. S., & Leibel, R. L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.04.007 · Cited by 32
Richard, A. J., Fuller, S., Fedorcenco, V., Beyl, R., Burris, T. P., Mynatt, R., Ribnicky, D. M., & Stephens, J. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098897 · Cited by 30
“However, evidence has since emerged demonstrating that disruption of adipocyte differentiation and/or expansion is maladaptive and leads to ectopic fat accumulation and metabolic dysfunction, including insulin resistance and T2DM [4,5].”
BackgroundInfluentialTrius‐Soler, M., & Moreno, J. J. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116192 · Cited by 38
“The hypertrophy of adipocytes in obese subjects stimulate immune cell infiltration and pro-inflammatory cytokines release that contributes to systemic low-grade inflammation and the recruitment of obesity [78].”
The flux of energy in critical illness and the obesity paradox
Jaitovich, A., & Hall, J. B. (2025) · Physiological Reviews · doi:10.1152/physrev.00029.2024 · Cited by 37
PAQRs: A Counteracting Force to Ceramides?
Holland, W. L., & Scherer, P. E. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.054817 · Cited by 31
“-cell function and insulin sensitivity despite substantially increased fat mass (Kim et al., 2007) The progestin and adipoQ receptors (PAQR) are a novel family of receptors that includes adiponectin receptors 1 and 2 (AdipoR1 and AdipoR2) and the membrane progesterone receptors and .”
BackgroundSelf-citationWainright, K. S., Fleming, N. J., Rowles, J. L., Welly, R. J., Zidon, T. M., Park, Y., Gaines, T. L., Scroggins, R. J., Anderson‐Baucum, E. K., Hasty, A. H., et al. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00042.2015 · Cited by 31
Clayton, Z. S., & McCurdy, C. E. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00364.2017 · Cited by 33
“WAT expansion has been shown to reduce adipose tissue inflammation in obesity (20).”
BackgroundMechanistic insights of adipocyte metabolism in regulating breast cancer progression
Zhang, F., & Liu, S. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104741 · Cited by 35
Adipose Tissue as Endocrine Organ
Sinal, C. J., & Goralski, K. B. (2009) · Oxidative stress and disease · doi:10.1201/9781420091311.ch2 · Cited by 34
Exon 2‐mediated deletion of Trem2 does not worsen metabolic function in diet‐induced obese mice
Winn, N. C., Wolf, E. M., Garcia, J. N., & Hasty, A. H. (2022) · The Journal of Physiology · doi:10.1113/jp283684 · Cited by 30
“The lack of a relationship between adipocyte hypertrophy and systemic insulin sensitivity observed herein might suggest ‘healthy’ adipocyte expansion similar to that observed in adipocyte fibrosis-resistant mouse models (Khan et al., 2009; Kim et al., 2007).”
ResultNiemann, B., Silber, R., & Rohrbach, S. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.02.008 · Cited by 32
“Furthermore, adiponectin has been suggested to act as a peripheral ‘‘starvation” signal promoting the storage of triglycerides preferentially in adipose tissue thereby reducing ectopic lipid deposition in nonadipose tissue (Kim et al., 2007).”
InfluentialWeksler‐Zangen, S., Jörns, A., Tarsi-Chen, L., Vernea, F., Aharon‐Hananel, G., Saada, A., Lenzen, S., & Raz, I. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00036.2013 · Cited by 30
Aydın, H. İ., Eser, A., Kaygusuz, İ., Yildirim, S., Çelik, T., Gündüz, S., & Kalman, S. (2015) · Journal of Perinatal Medicine · doi:10.1515/jpm-2014-0353 · Cited by 33
“In rat models of IUGR, the activation of PPAR γ both increases subcutaneous adiponectin expression and normalizes VAT deposition [30].”
BackgroundObesity Inhibits Angiogenesis Through TWIST1-SLIT2 Signaling
Hunyenyiwa, T., Hendee, K., Matus, K., Kyi, P., Mammoto, T., & Mammoto, A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.693410 · Cited by 32
“, liver, muscle, pancreas, heart) as well as in tumor tissues, promoting insulin resistance (Kim et al., 2007; Savage, 2009; Virtue and Vidal-Puig, 2010), cardiovascular diseases and tumor progression (Dong et al.”
BackgroundAAV-mediated BMP7 gene therapy counteracts insulin resistance and obesity
Casana, E., Jiménez, V., Jambrina, C., Sacristan, V., MUÑOZ, S. A., Rodó, J., Grass, I., García, M., Mallol, C., León, X., et al. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.03.007 · Cited by 29
Zheng, L., Sun, A., Han, S., Qi, R., Wang, R., Gong, X., & Xue, M. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1249401 · Cited by 34
A putative role for endogenous FGF-2 in FGF-1 mediated differentiation of human preadipocytes
Hutley, L. J., Newell, F., Kim, Y., Luo, X. L., Widberg, C., Shurety, W., Prins, J. B., & Whitehead, J. P. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.04.012 · Cited by 29
Murphy, E. L., Fang, J., Tu, Y., Cable, R. G., Hillyer, C. D., Sacher, R. A., Triulzi, D. J., Gottschall, J. L., & Busch, M. P. (2010) · The Journal of Infectious Diseases · doi:10.1086/654882 · Cited by 31
“Alternatively, an inflammatory state including macrophage infiltration of fat pads and increased production of IL-6 and TNF∀ has recently been linked to obesity and could contribute to the resolution of HCV infection[39,40].”
BackgroundAdiponectin Signaling and Metabolic Syndrome
Fu, Y. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00009-0 · Cited by 35
Obesity and Chronic Kidney Disease
Ritz, E., & Koleganova, N. (2009) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2009.06.007 · Cited by 29
Bagley, H. N., Wang, Y., Campbell, M. S., Yu, X., Lane, R. H., & Joss‐Moore, L. A. (2013) · Journal of Obesity · doi:10.1155/2013/312153 · Cited by 28
“When mice with excessive VAT deposition overexpress adiponectin, VAT is redistributed to SAT in association with improved metabolic parameters [12].”
BackgroundInfluentialYoon, J. W., Jung, C.-H., Kim, M.-K., Park, H. E., Park, K. S., Jang, H. C., Moon, M. K., Choi, S., & Koo, B. K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178741 · Cited by 31
Immunometabolic Activation of Invariant Natural Killer T Cells
Ververs, F. A., Kalkhoven, E., Land, B. V., Boes, M. L., & Schipper, H. S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01192 · Cited by 29
“Adiponectin overexpression in ob/ob obese mice protects against insulin resistance and AT inflammation (69), perhaps”
BackgroundLawrence, J. C., Newcomer, B. R., Buchthal, S. D., Sirikul, B., Oster, R. A., Hunter, G. R., & Gower, B. A. (2010) · Obesity · doi:10.1038/oby.2010.148 · Cited by 29
“Both processes may be affected by adiponectin, which promotes hyperplastic expansion of subcutaneous adipose tissue by increasing PPAR-γ activity (37).”
BackgroundYanagida, K., Igarashi, H., Yasuda, D., Kobayashi, D., Ohto‐Nakanishi, T., Akahoshi, N., Sekiba, A., Toyoda, T., Ishijima, T., Nakai, Y., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.97293 · Cited by 35
“Genetic mouse models have shown improvements in their metabolic profile through expansion of adipose tissue by modulating PPARγ activity (4), mitochondrial function (5), or production of adiponectin, an antidiabetic adipokine (6).”
BackgroundSt. John's Wort inhibits insulin signaling in murine and human adipocytes
Richard, A. J., Amini, Z., Ribnicky, D., & Stephens, J. M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.12.005 · Cited by 26
Unger, R. H., Scherer, P. E., & Holland, W. L. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-10-0774 · Cited by 27
“The authors were supported by the National Institutes of Health (NIH; grant K99-DK094973) and an American Heart Association Beginning Grant-in-Aid (12BGI-A8910006) to W.L.H. and NIH grants (R01-DK55758 and P01-DK088761) to P.E.S.”
MethodSelf-citationAnti-Inflammatory Diets for Obesity and Diabetes
Sears, B. (2009) · Journal of the American College of Nutrition · doi:10.1080/07315724.2009.10718115 · Cited by 29
“These transgenetic obese mice became even more obese, but there was normalization of blood glucose and lipid levels [67].”
BackgroundChronic Inflammation in Obesity and Cancer Cachexia
Divella, R., Gadaleta‐Caldarola, G., & Mazzocca, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11082191 · Cited by 36
Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution
Bozzetto, L., Prinster, A., Mancini, M., Giacco, R., Natale, C. D., Salvatore, M., Riccardi, G., Rivellese, A. A., & Annuzzi, G. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02372.x · Cited by 34
North, K. E., Graff, M., Franceschini, N., Reiner, A. P., Feitosa, M. F., Carr, J. J., Gordon‐Larsen, P., Wojczynski, M. K., & Borecki, I. B. (2011) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32834a94fb · Cited by 27
Yue, L., Christman, J. W., & Mazzone, T. (2008) · Endocrinology · doi:10.1210/en.2008-0340 · Cited by 32
Metadata
- Authors
- Kim, J.-Y., van de Wall, E., Laplante, M., Azzara, A., Trujillo, M. E., Hofmann, S. M., Schraw, T., Durand, J. L., Li, H., Li, G., Jelicks, L. A., Mehler, M. F., Hui, D. Y., Deshaies, Y., Shulman, G. I., Schwartz, G. J., & Scherer, P. E.
- Affiliations
- Université Laval (CA)
- Albert Einstein College of Medicine (US)
- University of Cincinnati (US)
- Howard Hughes Medical Institute (US)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Scherer, Philipp E.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2007-09-04
- Volume
- 117
- Issue
- 9
- Pages
- 2621-2637
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1950456
- OpenAlex
- W2159346623
- Cited by
- 1,310
- References
- 61
- Citations by year
- 2026: 22 · 2025: 35 · 2024: 46 · 2023: 43 · 2022: 67 · 2021: 66 · 2020: 57 · 2019: 64 · 2018: 67 · 2017: 73 · 2016: 62 · 2015: 76 · 2014: 96 · 2013: 115 · 2012: 88
- FWCI
- 58.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- American Heart Association
- National Institutes of Health (DK 59630, DK026687)
- Albert Einstein College of Medicine, Yeshiva University
- National Cancer Institute (R01CA112023)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 59630, R01 DK 55758, R01DK040936, U24DK059635, R01DK055758, DK026687, R01DK066618, U24DK059630, R24DK071030, R21DK075887, R24-DK071030-01, P30DK026687)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- adiponectin, leptin deficiency, ob/ob mice, morbid obesity, insulin resistance, adipose tissue expansion, ectopic fat deposition, PPARγ target genes, macrophage infiltration, systemic inflammation, triglyceride storage, beta-cell failure, metabolic profile
- MeSH terms
- Adipose Tissue, Animals, Animal Feed, Diglycerides, Fats, Gene Expression Regulation, Immunohistochemistry, Insulin, Insulin Resistance, Islets of Langerhans, Lipoproteins, Liver, Macrophages, Mice, Transgenic, Obesity, Organ Size, Phenotype, Triglycerides, Leptin, PPAR gamma, Mice, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.